91 related articles for article (PubMed ID: 3545749)
1. [Importance of the composition of various combination regimens in the chemotherapy of metastatic breast cancer].
Petru E; Schmähl D
Dtsch Med Wochenschr; 1987 Feb; 112(7):270-5. PubMed ID: 3545749
[No Abstract] [Full Text] [Related]
2. Carboplatin in combination therapy for metastatic breast cancer.
Perez EA
Oncologist; 2004; 9(5):518-27. PubMed ID: 15477636
[TBL] [Abstract][Full Text] [Related]
3. [Metastatic cancer of the breast. Study of intensive induction of remission chemotherapy. Controlled clinical trial].
Jouve M; Palangie T; Dorval T; Garcia-Giral E; Asselain B; Coutant M; Pouillart P
Bull Cancer; 1986; 73(6):683-4. PubMed ID: 3552083
[No Abstract] [Full Text] [Related]
4. Combination chemotherapy with vinorelbine (Navelbine) and mitoxantrone for metastatic breast cancer: a review.
Vogel CL
Semin Oncol; 1995 Apr; 22(2 Suppl 5):61-5. PubMed ID: 7740335
[TBL] [Abstract][Full Text] [Related]
5. The use of chemotherapy in metastatic breast cancer.
Garber JE; Henderson IC
Hematol Oncol Clin North Am; 1989 Dec; 3(4):807-21. PubMed ID: 2481671
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy for metastatic breast cancer.
Nabholtz JM; Reese DM; Lindsay MA; Riva A
Expert Rev Anticancer Ther; 2002 Apr; 2(2):169-80. PubMed ID: 12113239
[TBL] [Abstract][Full Text] [Related]
7. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial of combined hormone therapy (MAP + TAM) for metastatic breast cancer.
Pannuti F; Martoni A; Piana E; Tomasi L; Grieco A; Farris A; Saccani F; Baroni M
Chemioterapia; 1984 Aug; 3(4):211-5. PubMed ID: 6241846
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab: new indication. Metastatic breast cancer: many adverse effects.
Prescrire Int; 2008 Dec; 17(98):236. PubMed ID: 19422148
[No Abstract] [Full Text] [Related]
10. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
Tamura K
Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
[No Abstract] [Full Text] [Related]
11. Chemotherapy regimens in metastatic breast cancer.
Glück S
Clin Adv Hematol Oncol; 2011 Jan; 9(1):47-8. PubMed ID: 21326146
[No Abstract] [Full Text] [Related]
12. Breast cancer: metastatic.
Johnston S; Stebbing J
Clin Evid; 2002 Jun; (7):1579-602. PubMed ID: 12230774
[No Abstract] [Full Text] [Related]
13. Mitoxantrone-cyclophosphamide-fluorouracil-combination chemotherapy in metastatic breast cancer. 3-Year-follow-up.
Büyükünal E; Derman U; Serdengeçti S; Berkarda B
J Chemother; 1989 Jul; 1(4 Suppl):1201-2. PubMed ID: 16312833
[No Abstract] [Full Text] [Related]
14. Ixabepilone in metastatic breast cancer: complement or alternative to taxanes?
Tan AR; Toppmeyer DL
Clin Cancer Res; 2008 Nov; 14(21):6725-9. PubMed ID: 18980963
[No Abstract] [Full Text] [Related]
15. Chemotherapy benefits nearly all early breast cancer patients.
McNeil C
J Natl Cancer Inst; 1997 Jun; 89(12):838-9. PubMed ID: 9196246
[No Abstract] [Full Text] [Related]
16. Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
Köstler WJ; Brodowicz T; Zielinski CC;
J Natl Cancer Inst; 2010 Feb; 102(3):207; author reply 207-8. PubMed ID: 20054016
[No Abstract] [Full Text] [Related]
17. Cytokinetic-based versus conventional chemotherapy in metastatic breast cancer: a randomized study.
Conte PF; Rubagotti A; Falcone A; Gardin G; Nicolin A; Pronzato P; Rosso R; Amadori D; Gentilini P; Sismondi P
Chemioterapia; 1987 Jun; 6(2 Suppl):712-3. PubMed ID: 3334664
[No Abstract] [Full Text] [Related]
18. [Sequential combination chemotherapy in metastatic cancer of the breast].
Leone BA; Rabinovich MG; Strauss E; Arévalo E
Medicina (B Aires); 1984; 44(1):15-22. PubMed ID: 6549523
[No Abstract] [Full Text] [Related]
19. Paclitaxel combination therapy in the treatment of metastatic breast cancer.
Holmes FA
Semin Oncol; 1996 Oct; 23(5 Suppl 12):29-39. PubMed ID: 8941408
[TBL] [Abstract][Full Text] [Related]
20. [Doxorubicin and paclitaxel vs. 5-fluorouracyl, doxorubicin and cyclophosphamid in the first line treatment of metastatic breast cancer].
Nagykálnai T
Magy Onkol; 2002; 46(2):192-3. PubMed ID: 12202899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
